Longevity and C282Y mutation for haemochromatosis: survival of C282Y homozygotes does not preclude screening for HFE mutations
- PMID: 14576264
- PMCID: PMC259203
- DOI: 10.1136/bmj.327.7421.990-a
Longevity and C282Y mutation for haemochromatosis: survival of C282Y homozygotes does not preclude screening for HFE mutations
Comment on
-
Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: case control study of 492 French centenarians.BMJ. 2003 Jul 19;327(7407):132-3. doi: 10.1136/bmj.327.7407.132. BMJ. 2003. PMID: 12869454 Free PMC article. No abstract available.
References
-
- Willis G, Wimperis JZ, Smith KC, Fellows IW Jennings BA. Haemochromatosis gene C282Y homozygotes in an elderly male population. Lancet 1999;354: 221-2. - PubMed
-
- Willis G, Jennings BA, Wimperis JZ. The cost and benefit of population screening for HFE mutations. J Med Genet 1999;36(suppl): S68.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical